Literature DB >> 2143552

The role of anticholinergic antimuscarinic bronchodilator therapy in children.

M Silverman1.   

Abstract

In the intricate system of control of airway caliber, the cholinergic (muscarinic) sympathetic nervous system has an important role. Despite the paucity of physiologic or clinical data, it is clear that anticholinergic, antimuscarinic bronchodilator therapy is useful in the management of childhood airway disease. Ipratropium bromide is the only safe and adequately studied agent. It is effective in conjunction with beta-agonists in acute severe childhood asthma and has an important role in the management of wheezy infants and in chronic lung disease of prematurity (bronchopulmonary dysplasia).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143552     DOI: 10.1007/bf02718146

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  37 in total

1.  Effects of inhaled metaproterenol and atropine on the pulmonary mechanics of infants with bronchopulmonary dysplasia.

Authors:  L C Kao; D J Durand; B G Nickerson
Journal:  Pediatr Pulmonol       Date:  1989

2.  Frequent administration by inhalation of salbutamol and ipratropium bromide in the initial management of severe acute asthma in children.

Authors:  J Reisman; M Galdes-Sebalt; F Kazim; G Canny; H Levison
Journal:  J Allergy Clin Immunol       Date:  1988-01       Impact factor: 10.793

3.  Nebulised ipratropium and salbutamol in asthma.

Authors:  J Storr; W Lenney
Journal:  Arch Dis Child       Date:  1986-06       Impact factor: 3.791

4.  A short tour around the muscarinic receptor.

Authors:  N J Gross; P J Barnes
Journal:  Am Rev Respir Dis       Date:  1988-10

5.  Determination of dose-response relationship for nebulized ipratropium in asthmatic children.

Authors:  A Davis; F Vickerson; G Worsley; C Mindorff; F Kazim; H Levison
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

6.  Nebulised therapy in acute severe bronchiolitis in infancy.

Authors:  G M Stokes; A D Milner; I G Hodges; R L Henry; M C Elphick
Journal:  Arch Dis Child       Date:  1983-04       Impact factor: 3.791

7.  The bronchial response to cold air challenge: evidence for different mechanisms in normal and asthmatic subjects.

Authors:  R W Heaton; A F Henderson; B J Gray; J F Costello
Journal:  Thorax       Date:  1983-07       Impact factor: 9.139

8.  Bronchodilator effect of fenoterol and ipratropium bromide in infants with acute wheezing: use of MDI with a spacer device.

Authors:  J Mallol; L Barrueto; G Girardi; O Toro
Journal:  Pediatr Pulmonol       Date:  1987 Sep-Oct

9.  Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children.

Authors:  P D Sly; L I Landau; A Olinsky
Journal:  Thorax       Date:  1987-05       Impact factor: 9.139

10.  Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves.

Authors:  A Prendiville; S Green; M Silverman
Journal:  Thorax       Date:  1987-02       Impact factor: 9.139

View more
  2 in total

Review 1.  Management of children with severe asthma exacerbation in the emergency department.

Authors:  Benjamin Volovitz; Moshe Nussinovitch
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 2.  Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review.

Authors:  L H Plotnick; F M Ducharme
Journal:  BMJ       Date:  1998-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.